Skip to main content
NCBI home page
Heart logoLink to Heart
. 2000 Dec;84(6):668–669. doi: 10.1136/heart.84.6.668

Interleukin 18 in acute myocardial infarction

Y SETA 1, T KANDA 1, T TANAKA 1, M ARAI 1, K SEKIGUCHI 1, T YOKOYAMA 1, M KURIMOTO 1, J TAMURA 1, M KURABAYASHI 1
PMCID: PMC1729510  PMID: 11083751

Full Text

The Full Text of this article is available as a PDF (97.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dao T., Ohashi K., Kayano T., Kurimoto M., Okamura H. Interferon-gamma-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells. Cell Immunol. 1996 Nov 1;173(2):230–235. doi: 10.1006/cimm.1996.0272. [DOI] [PubMed] [Google Scholar]
  2. Gaspardone A., Crea F., Versaci F., Tomai F., Pellegrino A., Chiariello L., Gioffrè P. A. Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina. Am J Cardiol. 1998 Aug 15;82(4):515–518. doi: 10.1016/s0002-9149(98)00370-1. [DOI] [PubMed] [Google Scholar]
  3. Kajstura J., Cheng W., Reiss K., Clark W. A., Sonnenblick E. H., Krajewski S., Reed J. C., Olivetti G., Anversa P. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest. 1996 Jan;74(1):86–107. [PubMed] [Google Scholar]
  4. Kochiadakis G. E., Igoumenidis N. E., Marketou M. E., Kaleboubas M. D., Simantirakis E. N., Vardas P. E. Low dose amiodarone and sotalol in the treatment of recurrent, symptomatic atrial fibrillation: a comparative, placebo controlled study. Heart. 2000 Sep;84(3):251–257. doi: 10.1136/heart.84.3.251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Laine P., Kaartinen M., Penttilä A., Panula P., Paavonen T., Kovanen P. T. Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery. Circulation. 1999 Jan 26;99(3):361–369. doi: 10.1161/01.cir.99.3.361. [DOI] [PubMed] [Google Scholar]
  6. Liuzzo G., Biasucci L. M., Gallimore J. R., Grillo R. L., Rebuzzi A. G., Pepys M. B., Maseri A. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med. 1994 Aug 18;331(7):417–424. doi: 10.1056/NEJM199408183310701. [DOI] [PubMed] [Google Scholar]
  7. Liuzzo G., Biasucci L. M., Rebuzzi A. G., Gallimore J. R., Caligiuri G., Lanza G. A., Quaranta G., Monaco C., Pepys M. B., Maseri A. Plasma protein acute-phase response in unstable angina is not induced by ischemic injury. Circulation. 1996 Nov 15;94(10):2373–2380. doi: 10.1161/01.cir.94.10.2373. [DOI] [PubMed] [Google Scholar]
  8. Maisel A., Cesario D., Baird S., Rehman J., Haghighi P., Carter S. Experimental autoimmune myocarditis produced by adoptive transfer of splenocytes after myocardial infarction. Circ Res. 1998 Mar 9;82(4):458–463. doi: 10.1161/01.res.82.4.458. [DOI] [PubMed] [Google Scholar]
  9. Menotti A., Lanti M., Puddu P. E., Kromhout D. Coronary heart disease incidence in northern and southern European populations: a reanalysis of the seven countries study for a European coronary risk chart. Heart. 2000 Sep;84(3):238–244. doi: 10.1136/heart.84.3.238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Neumann F. J., Ott I., Gawaz M., Richardt G., Holzapfel H., Jochum M., Schömig A. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation. 1995 Aug 15;92(4):748–755. doi: 10.1161/01.cir.92.4.748. [DOI] [PubMed] [Google Scholar]
  11. Okamura H., Tsutsi H., Komatsu T., Yutsudo M., Hakura A., Tanimoto T., Torigoe K., Okura T., Nukada Y., Hattori K. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature. 1995 Nov 2;378(6552):88–91. doi: 10.1038/378088a0. [DOI] [PubMed] [Google Scholar]
  12. Pepys M. B. C-reactive protein fifty years on. Lancet. 1981 Mar 21;1(8221):653–657. doi: 10.1016/s0140-6736(81)91565-8. [DOI] [PubMed] [Google Scholar]
  13. Pudil R., Pidrman V., Krejsek J., Gregor J., Tichý M., Andrýs C., Drahosová M. Cytokines and adhesion molecules in the course of acute myocardial infarction. Clin Chim Acta. 1999 Feb;280(1-2):127–134. doi: 10.1016/s0009-8981(98)00179-x. [DOI] [PubMed] [Google Scholar]
  14. Toft A. D., Boon N. A. Thyroid disease and the heart. Heart. 2000 Oct;84(4):455–460. doi: 10.1136/heart.84.4.455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Wiegers S. E., St John Sutton M. When should ACE inhibitors or warfarin be discontinued after myocardial infarction? Heart. 2000 Oct;84(4):361–362. doi: 10.1136/heart.84.4.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Wilkins M. R., Roses A. D., Clifford C. P. Pharmacogenetics and the treatment of cardiovascular disease. Heart. 2000 Oct;84(4):353–354. doi: 10.1136/heart.84.4.353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. de Feyter P. J., Nieman K., van Ooijen P., Oudkerk M. Non-invasive coronary artery imaging with electron beam computed tomography and magnetic resonance imaging. Heart. 2000 Oct;84(4):442–448. doi: 10.1136/heart.84.4.442. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES